Novavax
NVAX
#5794
Rank
C$1.50 B
Marketcap
C$9.27
Share price
0.75%
Change (1 day)
-25.69%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): C$0.54 Billion

According to Novavax's latest financial reports the company's current earnings are C$1.02 Billion. In 2024 the company made an earning of -C$0.22 Billion, an increase over its 2023 earnings that were of -C$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.54 B-350.48%
2024 -C$0.22 Billion-70.39%
2023 -C$0.73 Billion-16.59%
2022 -C$0.88 Billion-62.58%
2021 -C$2.34 Billion320.54%
2020 -C$0.56 Billion234.22%
2019 -C$0.17 Billion-30.17%
2018 -C$0.24 Billion1.69%
2017 -C$0.24 Billion-36.44%
2016 -C$0.37 Billion70.4%
2015 -C$0.22 Billion89.27%
2014 -C$0.12 Billion59.83%
2013 -C$71.38 Million81.9%
2012 -C$39.24 Million50.33%
2011 -C$26.11 Million
2009 -C$51.52 Million8.8%
2008 -C$47.35 Million18.01%
2007 -C$40.13 Million18.33%
2006 -C$33.91 Million168.31%
2005 -C$12.64 Million-62.51%
2004 -C$33.71 Million52.4%
2003 -C$22.12 Million-28.21%
2002 -C$30.81 Million
2000 -C$17.56 Million177%
1999 -C$6.34 Million-11.54%
1998 -C$7.17 Million10.64%
1997 -C$6.48 Million-9.62%
1996 -C$7.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
C$28.47 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.35 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$9.12 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.03 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$16.33 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.62 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-C$11.2 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.84 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.36 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA